Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer.

Asghar US, Barr AR, Cutts R, Beaney M, Babina I, Sampath D, Giltnane J, Lacap JA, Crocker L, Young A, Pearson A, Herrera-Abreu MT, Bakal C, Turner NC.

Clin Cancer Res. 2017 Sep 15;23(18):5561-5572. doi: 10.1158/1078-0432.CCR-17-0369. Epub 2017 Jun 12.

2.

Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer.

Herrera-Abreu MT, Palafox M, Asghar U, Rivas MA, Cutts RJ, Garcia-Murillas I, Pearson A, Guzman M, Rodriguez O, Grueso J, Bellet M, Cort├ęs J, Elliott R, Pancholi S, Baselga J, Dowsett M, Martin LA, Turner NC, Serra V.

Cancer Res. 2016 Apr 15;76(8):2301-13. doi: 10.1158/0008-5472.CAN-15-0728. Epub 2016 Mar 28. Erratum in: Cancer Res. 2016 Oct 1;76(19):5907.

3.

The history and future of targeting cyclin-dependent kinases in cancer therapy.

Asghar U, Witkiewicz AK, Turner NC, Knudsen ES.

Nat Rev Drug Discov. 2015 Feb;14(2):130-46. doi: 10.1038/nrd4504. Review.

4.

Effect of alkaline pretreatment on delignification of wheat straw.

Asghar U, Irfan M, Iram M, Huma Z, Nelofer R, Nadeem M, Syed Q.

Nat Prod Res. 2015;29(2):125-31. doi: 10.1080/14786419.2014.964712. Epub 2014 Oct 6.

PMID:
25285562
5.

Evaluation of nutritional and sub-acute toxicological study of plant based supplement of Achyranthes aspera.

Fatima N, Dar NG, Imran H, Sohail T, Asghar U, Yaqeen Z, Syed S, Jamil K.

Pak J Pharm Sci. 2014 Sep;27(5):1199-202.

PMID:
25176360
6.

Influence of phytic acid and its metal complexes on the activity of pectin degrading polygalacturonase.

Asghar U, Rehman HU, Qader SA, Maqsood ZT.

Carbohydr Polym. 2013 Jun 5;95(1):167-70. doi: 10.1016/j.carbpol.2013.02.065. Epub 2013 Mar 5.

PMID:
23618254
7.

Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resection.

Constantinidou A, Cunningham D, Shurmahi F, Asghar U, Barbachano Y, Khan A, Mudan S, Rao S, Chau I.

Clin Colorectal Cancer. 2013 Mar;12(1):15-22. doi: 10.1016/j.clcc.2012.07.002. Epub 2012 Sep 26.

PMID:
23021126
8.

Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?

Asghar U, Meyer T.

J Hepatol. 2012 Mar;56(3):686-95. doi: 10.1016/j.jhep.2011.07.031. Epub 2011 Oct 2. Review.

9.

Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancer.

Asghar U, Hawkes E, Cunningham D.

Clin Colorectal Cancer. 2010 Dec;9(5):274-81. doi: 10.3816/CCC.2010.n.040. Review.

PMID:
21208841
10.

Rechallenge with platinum plus fluoropyrimidine +/- epirubicin in patients with oesophagogastric cancer.

Okines AF, Asghar U, Cunningham D, Ashley S, Ashton J, Jackson K, Hawkes E, Chau I.

Oncology. 2010;79(1-2):150-8. doi: 10.1159/000322114. Epub 2010 Dec 8.

PMID:
21150230

Supplemental Content

Loading ...
Support Center